Innovative liquid formulation, based on the excipient technology.


AQ001S, a soluble steroid for nebulization

By reformulating existing ICS with its proprietary excipient, Aquilon Pharma makes ICS soluble in water.

The answer to today’s needs in the field of asthma medication

Inhaled corticosteroids (ICS) are the basic treatment option to suppress airway inflammation.

ICS can be delivered via several types of devices, however it is not commonly delivered via soft mist nebulization.Vibrating mesh nebulizers have become the first choice for new nebulized pharmaceutical drugs. Unfortunately, there is no ICS in solution available yet for these devices. Aquilon Pharma’s AQ001S liquid formulation (solution) for nebulization is the key.


Aquilon Pharma has strong patents covering its excipient platform up to 2039. Several patents are granted in most of the key countries around the globe.

Medical advantages

Thanks to its combination with the excipient, AQ001S …

  • Shows prolonged airway activity for the same ICS concentration
  • Has a better diffusion in the lungs
  • Is more efficient than existing suspensions at a lower dose
  • Improves the efficiency of the administration
  • Minimizes the risk of side effects
  • Minimizes the risk of misuse


Contact us

Do you have a question? Let's get in touch.